📰 Eceptor News
Page 49 - Eceptor News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eceptor. Real-time updates on events, politics, business and more.
May 4, 2023
Strategies to treat pain without triggering dangerous side effects such as euphoria and addiction have proven elusive.
May 3, 2023
Artificial intelligence (AI) can analyze breast mass images from low-cost portable ultrasound machines and accurately identify cancer, according to a study published in Radiology, a journal of the Radiological Society of North America.
May 2, 2023
Press Release: Medigene expands end-to-end technology platform through worldwide, exclusive license of a CD40L-CD28 Costimulatory Switch Receptor further enhancing potential to treat solid tumors
May 2, 2023
Medigene accelerates the expansion of its end-to-end platform of multiple, combinable, exclusive and proprietary technologies with the potential to create best-in-class T cell receptor engineered T... | May 2, 2023
May 1, 2023
This study aimed to investigate the potential influence of short-term maternal diet and current body composition on human milk oligosaccharide (HMO) profiles in mature human milk. The study found a lack of clear and consistent associations between maternal nutrition and HMO concentrations in mature human milk from healthy lactating women with adequate dietary intake.
April 28, 2023
A team of researchers from the University of California, Irvine, have revealed the first crystal structures of the receptor-binding domain of botulinum neurotoxin E (BoNT/E) in complex with its human neuronal receptors, synaptic vesicle glycoprotein 2A (SV2A).
April 28, 2023
A new approach to the genetic engineering of cells promises significant improvements in speed, efficiency, and reduction in cellular toxicity compared to current methods.
April 27, 2023
Researchers explored the association between SARS-CoV-2 spike protein and burst activities in neurons.
April 27, 2023
Researchers explored the response of respiratory epithelial cells in deers to SARS-CoV-2.
April 26, 2023
Researchers at Nagoya University in Japan have discovered a receptor, sigma-1 receptor, and a protein, ATAD3A, that are associated with Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease.